Mayo Clinic
Rochester, Minnesota, United States
238 recruiting
Showing 1–20 of 575 trials
Recruiting
Phase 2Phase 3
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Neoplasms
Celgene1,541 enrolled209 locationsNCT03435796
Recruiting
Phase 2
An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
ToLymph Inc.42 enrolled2 locationsNCT06693336
Recruiting
Phase 2
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Breast CancerTriple-Negative Breast CancerMetastatic Breast Cancer+2 more
UNC Lineberger Comprehensive Cancer Center700 enrolled4 locationsNCT07340541
Recruiting
Phase 3
A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary hemorrhagic telangiectasia
Vaderis Therapeutics AG240 enrolledNCT07743671
Recruiting
Not Applicable
The Fourth Left Atrial Appendage Occlusion Study
Atrial FibrillationStroke, IschemicSystemic Embolism
Hamilton Health Sciences Corporation4,000 enrolled140 locationsNCT05963698
Recruiting
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
Ankle Rheumatoid ArthritisArthritis of AnkleFailure, Prosthesis
Exactech370 enrolled2 locationsNCT05619588
Recruiting
Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)156 enrolled22 locationsNCT04047628
Recruiting
Not Applicable
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Cardiac Rhythm DisorderBradycardiaAV Block+1 more
Biotronik, Inc.325 enrolled23 locationsNCT07118358
Recruiting
Phase 4
Statins to Prevent Cancer Associated Blood Clots
CancerVenous ThromboembolismCardiovascular Events
Brigham and Women's Hospital4,000 enrolled2 locationsNCT07303816
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Rheumatoid ArthritisInfectionsAnkylosing Spondylitis+6 more
Exactech20,000 enrolled38 locationsNCT05603728
Recruiting
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
Diabetic Retinal Disease
Jaeb Center for Health Research450 enrolledNCT07270133
Recruiting
Not Applicable
Zenith® Fenestrated+ Clinical Study
Juxtarenal Aortic AneurysmAortic Aneurysm, AbdominalPararenal Aneurysm+1 more
Cook Research Incorporated105 enrolled33 locationsNCT04875429
Recruiting
Phase 1Phase 2
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Low-grade Upper Tract Urothelial Carcinoma
Ferring Pharmaceuticals20 enrolled9 locationsNCT06668493
Recruiting
Phase 3
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim390 enrolled165 locationsNCT07544654
Recruiting
Phase 3
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Daiichi Sankyo686 enrolled237 locationsNCT06899126
Recruiting
Phase 3
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Amyotrophic Lateral Sclerosis
Prilenia500 enrolled56 locationsNCT07322003
Recruiting
Not Applicable
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Aortic Valve InsufficiencyAortic Insufficiencyaortic regurgitation
JenaValve Technology, Inc.1,016 enrolled29 locationsNCT06608823
Recruiting
Phase 3
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals270 enrolled2 locationsNCT07393282
Recruiting
Phase 1
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Lupus Nephritis (LN)
Regeneron Pharmaceuticals90 enrolled18 locationsNCT06975787
Recruiting
Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Gilead Sciences402 enrolled205 locationsNCT06051617